Showing posts with label Glaxosmithkline. Show all posts
Showing posts with label Glaxosmithkline. Show all posts

Tuesday, March 20, 2018

Big Pharma Paid Millions in Secret Settlements After Antidepressants Linked to Mass Murder

 Big Pharma Paid Millions in Secret Settlements After Antidepressants Linked to Mass Murder | Big-Pharma-medicine-pills-money | Big Pharma General Health Medical & Health Special Interests US News


By Rachel Blevins, thefreethoughtproject.com | 


Every time there are reports of a mass shooting, there are a number of people who automatically question whether the suspect had mental health issues or was taking prescription medications such as antidepressants.


While history has shown that the most notorious mass shooters in this century were taking antidepressants or Selective Serotonin Reuptake Inhibitors (SSRIs) before they carried out the deadly rampages, there are a number of killings that have been linked directly to the dangerous drugs. In fact, the pharmaceutical companies behind the most popular SSRI’s have paid hundreds of millions of dollars in damages:


Eli Lilly Paid Secret Settlements to Survivors After Man on Prozac Went on Shooting Rampage in 1989


Joseph T. Wesbecker, 47, carried out a mass shooting in which he shot 20 workers at Standard Gravure Corp. in Kentucky, in September 1989. Eight of the victims were fatally wounded, and Wesbecker ended the rampage by shooting and killing himself.


Just one month earlier, Wesbecker had started taking the antidepressant Prozac, which included side effects such as “obsession with suicide and dangerously violent behavior,” according to an article in the American Journal of Psychiatry.


When the survivors of the shooting filed a lawsuit against Eli Lilly arguing that it had known about the propensity of Prozac to cause violent outbursts and suicidal tendencies, the company convinced the victims to agree to secret settlements outside of court.


GlaxoSmithKline Paid $6.4 Million to the Family of a Man Who Murdered Three Family Members Hours After Taking Paxil in 1998


Donald Schell, 60, was prescribed the antidepressant Paxil to treat depression in Wyoming in February 1998. Within hours of taking the first dosage, he burst into a fit of rage and fatally shot his wife, Rita; their daughter, Deborah Tobin; and their 9-month-old granddaughter, Alyssa.


Schell then shot and killed himself. His remaining family members filed a wrongful death lawsuit against the pharmaceutical company behind Paxil, and they were awarded $6.4 million based on “the company’s failure to sufficiently warn doctors and patients that the effects of the drug could include agitation and violence.”


GlaxoSmithKline Also Paid $3 Million to the Widow of a Man Who Committed Suicide After Taking Paxil in 2010


Stewart Dolin, 57, was working as a corporate attorney in Illinois when he was prescribed the generic version of the antidepressant Paxil for depression and anxiety. While taking the drug, he committed suicide by jumping in front of a Chicago Transit Authority train.


His widow, Wendy Dolin, filed a lawsuit against GlaxoSmithKline, arguing that the company failed to warn her husband’s doctor that the drug he was being prescribed would increase his risk of suicidal behavior, which led to his death.


“This for me has not just been about the money. This has always been about awareness to a health issue, and the public has to be aware of this,” Wendy Dolin told the Chicago Tribune after she was awarded $3 million in compensation.


While the cases mentioned above are notable because they received significant media attention, there is still an overwhelming number of lawsuits that stemmed from cases in which pharmaceutical companies paid millions of dollars for failing to warn doctors that the antidepressants they were prescribing could drive patients to kill themselves and others.


According to reports, the first lawsuit involving a Paxil suicide case went to trial in 2001, and since then, GlaxoSmithKline has paid more than $390 million in settlements or verdicts for Paxil-related cases. If that is the price they are willing to pay, then the profit they are making off of the controversial drug must be incredible.


The post Big Pharma Paid Millions in Secret Settlements After Antidepressants Linked to Mass Murder appeared first on The Sleuth Journal.

Big Pharma Paid Millions in Secret Settlements After Antidepressants Linked to Mass Murder

 Big Pharma Paid Millions in Secret Settlements After Antidepressants Linked to Mass Murder | Big-Pharma-medicine-pills-money | Big Pharma General Health Medical & Health Special Interests US News


By Rachel Blevins, thefreethoughtproject.com | 


Every time there are reports of a mass shooting, there are a number of people who automatically question whether the suspect had mental health issues or was taking prescription medications such as antidepressants.


While history has shown that the most notorious mass shooters in this century were taking antidepressants or Selective Serotonin Reuptake Inhibitors (SSRIs) before they carried out the deadly rampages, there are a number of killings that have been linked directly to the dangerous drugs. In fact, the pharmaceutical companies behind the most popular SSRI’s have paid hundreds of millions of dollars in damages:


Eli Lilly Paid Secret Settlements to Survivors After Man on Prozac Went on Shooting Rampage in 1989


Joseph T. Wesbecker, 47, carried out a mass shooting in which he shot 20 workers at Standard Gravure Corp. in Kentucky, in September 1989. Eight of the victims were fatally wounded, and Wesbecker ended the rampage by shooting and killing himself.


Just one month earlier, Wesbecker had started taking the antidepressant Prozac, which included side effects such as “obsession with suicide and dangerously violent behavior,” according to an article in the American Journal of Psychiatry.


When the survivors of the shooting filed a lawsuit against Eli Lilly arguing that it had known about the propensity of Prozac to cause violent outbursts and suicidal tendencies, the company convinced the victims to agree to secret settlements outside of court.


GlaxoSmithKline Paid $6.4 Million to the Family of a Man Who Murdered Three Family Members Hours After Taking Paxil in 1998


Donald Schell, 60, was prescribed the antidepressant Paxil to treat depression in Wyoming in February 1998. Within hours of taking the first dosage, he burst into a fit of rage and fatally shot his wife, Rita; their daughter, Deborah Tobin; and their 9-month-old granddaughter, Alyssa.


Schell then shot and killed himself. His remaining family members filed a wrongful death lawsuit against the pharmaceutical company behind Paxil, and they were awarded $6.4 million based on “the company’s failure to sufficiently warn doctors and patients that the effects of the drug could include agitation and violence.”


GlaxoSmithKline Also Paid $3 Million to the Widow of a Man Who Committed Suicide After Taking Paxil in 2010


Stewart Dolin, 57, was working as a corporate attorney in Illinois when he was prescribed the generic version of the antidepressant Paxil for depression and anxiety. While taking the drug, he committed suicide by jumping in front of a Chicago Transit Authority train.


His widow, Wendy Dolin, filed a lawsuit against GlaxoSmithKline, arguing that the company failed to warn her husband’s doctor that the drug he was being prescribed would increase his risk of suicidal behavior, which led to his death.


“This for me has not just been about the money. This has always been about awareness to a health issue, and the public has to be aware of this,” Wendy Dolin told the Chicago Tribune after she was awarded $3 million in compensation.


While the cases mentioned above are notable because they received significant media attention, there is still an overwhelming number of lawsuits that stemmed from cases in which pharmaceutical companies paid millions of dollars for failing to warn doctors that the antidepressants they were prescribing could drive patients to kill themselves and others.


According to reports, the first lawsuit involving a Paxil suicide case went to trial in 2001, and since then, GlaxoSmithKline has paid more than $390 million in settlements or verdicts for Paxil-related cases. If that is the price they are willing to pay, then the profit they are making off of the controversial drug must be incredible.


The post Big Pharma Paid Millions in Secret Settlements After Antidepressants Linked to Mass Murder appeared first on The Sleuth Journal.

Wednesday, June 7, 2017

Lead Developer of HPV Vaccines Comes Clean, Warns Parents and Young Girls It’s All A Giant Deadly Scam

Lead Developer of HPV Vaccines Comes Clean, Warns Parents and Young Girls It’s All A Giant Deadly Scam | Lead-Developer-Of-HPV-Vaccines-Comes-Clean-To-Warn-Parents-Young-Girls | Big Pharma Medical & Health Sleuth Journal Special Interests Vaccines

(Organic and Healthy) Based on their study, Rail and study co-author Abby Lippman, a McGill University professor emeritus, published an op-ed article in Montreal’s Le Devoir newspaper questioning the safety and benefits of human papillomavirus vaccines. Their op-ed urged Quebec to halt HPV immunization until its dangers are independently investigated. Of course they were roundly attacked through the Canadian mainstream media.

The mainstream media piled on with remarks from the usual “prestigious” medical professionals who asserted HPV vaccinations safety and remarkable success at reducing ovarian cancer. Fortunately, several comments on Canada’s National Post article favored the Rail-Lippman viewpoint despite the article’s slyly negative slant toward their findings.


Oh, of course statistics provided by pro-vaccine agencies and Big Pharma were included in the National Post article that “prove” HPV vaccine’s efficacy and safety.


Somehow these “prestigious” medical officials have ignored the adverse reaction cases reported internationally among teenage girls, ranging from chronic fatigue to chronic seizures to partial and complete paralysis. The HPV vaccines, Gardasil by Merck and Cervarix by GlaxoSmithKline (GSK) have been pushed onto families with teenage girls and now teenage boys as cancer preventatives.


The Rail-Lippman four-year study involved 170 parents of teenage girls who were given the HPV shots, which usually are administered sequentially in a series of three. Rail has been the main recipient of pro-vaccine hysteria criticism, and she’s not budging from what she knows to be true.


“I’m sort of raising a red flag, out of respect for what I’ve found in my own study, and for the despair of parents who had totally perfect 12-year-olds who are now in their beds, too tired to go to school,” Rail said. “Yes, we’re going against the grain, and we are going against those who are believed, i.e. doctors and nurses and people in public health.”


Every Mother of a Vaccine Injured Child Was Once Pro-Vaccine


If you’re old enough to remember Mr. T, a favorite statement of his was “pity the poor fool(s)”. That’s my thought for the average vaccine indoctrinated sheeple. But my thoughts get nastier with the manic frothing-at-the-mouth vaccine fanatics, and downright vicious with the vaccine industry and its celebrated spokesman Dr. Paul Offit.


Offit has maintained that a newborn can receive 1,000 vaccinations safely in a day and aluminum is vital to our health. Offit is a mainstream media darling. Ignore Offit. He’s off it and has made millions with his vaccine patent. And ignore the presstitutes who feed off him.


In case you’re wondering, breast milk feeding supports a newborn while its immune system is developing over the next two or so years. And unbound or free aluminum, the stuff used in almost all vaccines, is a neurological toxin.


A couple of years ago, one of the lead HPV vaccine developers for Merck’s Gardasil, Dr. Diane Harper, came clean and warned that Gardasil was not only ineffective and unnecessary, it was dangerous. Harper mentioned the medically known fact that 98 percent of HPV warts among sexually active women heal on their own within a year or two.


Lead Developer of HPV Vaccines Comes Clean, Warns Parents and Young Girls It’s All A Giant Deadly Scam | gardasil-med | Big Pharma Medical & Health Sleuth Journal Special Interests Vaccines

Besides, Pap smears are still the recommended watch tower for cervical cancer, even if HPV shots are administered. After coming clean she reportedly sort of recanted. Maybe her pension was threatened, or her family. Who knows? You can see more of what she had originally said here.


Keep in mind it’s estimated that only around 5 percent of vaccine adverse events are reported to the CDC’s Vaccine Adverse Event Reporting Service (VAERS) when you look over this graphic display from the Daily Sheeple.




Paul Fassa is a contributing staff writer for REALfarmacy.com. His pet peeves are the Medical Mafia’s control over health and the food industry and government regulatory agencies’ corruption. Paul’s contributions to the health movement and global paradigm shift are well received by truth seekers. Visit his blog by following this linkand follow him on Twitter here


Sources:



Saturday, April 22, 2017

Thousands Sue Merck for Shingles Vaccine “Causing What It’s Supposed to Prevent”

shingles



Attorney Troy Bouk was recently interviewed by Ring of Fire’s Farron Cousins to discuss the shingles vaccine Zostavax, the issues related to its effectiveness and the problems that are associated with the product, including the fact that the drugmaker’s vaccine seems to cause the very affliction that it seeks to prevent — and, according to a massive lawsuit, thousands of victims agree.


While we have everyone from attorneys to biologists, to political scientists who contribute to the Free Thought Project, none of us are doctors, so we do not make recommendations about what you and your family should do in regards to vaccination. That being said, the drug makers have an incentive for you not to see this information which means it will not be reported on in the mainstream media as their advertising dollars are tied directly to these companies. So, we find that it is our duty to spread this information and with your help sharing it, we can have a massive effect.



In the interview with Cousins, Bouk explained that Zostavax is made with a live strain of the shingles virus and described the complications that are associated with shingles. Shingles is caused by the varicella-zoster virus, which is the same virus that causes chicken pox. The varicella-zoster virus lies dormant in people who have had chicken pox, but sometimes the virus reawakens and produces shingles.


The virus often manifests as a painful rash, and can also lead to encephalitis, vision loss and postherpetic neuralgia. Bouk said that the virus sometimes “tends to get into your central nervous system, and then, once in there, it wreaks some havoc by usually causing swelling which ends up with these other medical problems. That’s the situation with the vaccine itself, is that Merck hasn’t warned anyone about those indications.”



READ MORE:  In the US Millions of Infants & Toddlers Given Psychiatric Drugs for No Reason and It"s Deadly



Cousins asked Bouk about the effectiveness of Zostavax, to which Bouk replied:



“The FDA has approved the vaccine for people 50 years of age and older, whereas the CDC only recommends that those individuals 60 years of age and older get it. The reason is that once you have had the Zostavax shot, the FDA says it only lasts for about four years. It’s not proven to last any longer than that. Let’s say you’re 55 years old. It may stay in your system till you’re 60, but you actually are at the greatest risk of getting shingles when you’re in your 60s. That’s why the CDC recommends that you really don’t get it until you’re in your 60s, because that’s probably when you’re going to need it the most.”


Book’s claim regarding the CDC’s recommendation is indeed correct. According to the CDC’s website, the agency specifically advises Zostavax to be given to people aged 60 and older and does not provide a recommendation for people between the ages of 50 and 59. The CDC warns that people in the 50-59 age group who receive the Zostavax shot may lose the vaccine’s protection benefits by the time they reach age 60, stating that “adults vaccinated before age 60 years might not be protected later in life when the risk for shingles and its complications are greatest.”


Despite the CDC’s caution against administering Zostavax to people under 60, the FDA approves the vaccine for people age 50 and older, and Merck uses the FDA’s approval to market the vaccine to that age group. Zostamax sales reached $749 million in 2015.



READ MORE:  Amish Father Arrested, Facing Decades in Prison for Selling Products with Essential Oils



The true efficacy of Zostavax is unclear. The CDC states that the drug “reduced the risk of shingles by 51%” based on a study of 38,000 people age 60 and up. Reuters reported that Zostavax’s effectiveness “varies between 18 and 70 percent, and it declines noticeably in older people.”


A second shingles vaccine from drug manufacturer GlaxoSmithKline, Shingrix, may be available if the FDA approves their filing. Shingrix, a two-dose vaccine, distinguishes itself from Zostavax because it’s derived from a protein of the virus rather than a live strain. The efficacy of Shingrix is more impressive, as Reuters noted that “in clinical trials, GSK’s vaccine remained 90 percent effective in people over age 70, even four years after injections.”


Merck has explicitly stated that those who receive the Zostavax vaccine “may still get shingles.” However, Bouk argued that some people may be contracting shingles as a side effect of the vaccine itself due to the live virus strain in the vaccine, not because people are experiencing shingles despite the vaccine.


Bouk went on to say that “there is a study out there that shows that in 50% of the patients that actually get the vaccine, that sometimes they don’t get shingles — the virus goes straight to manifesting in the central nervous system. It’s possible that you could get the vaccine and get meningitis or encephalitis without ever actually exhibiting shingles.” Bouk advises that patients weigh the risks of Zostavax before receiving the vaccine.


While GSK seeks approval of Shingrix, which could lead to their product edging out Zostavax, a large number of claims have been filed against Merck. The Mark J. Bern Partners law firm “is currently representing nearly 5000 claimants and has thousands more filings to follow.”



READ MORE:  Even DEA Tyrants are Waking Up, Letter Reveals Plan to Downgrade Pot from Schedule 1 by July



Marc J. Bern said that his firm has been “investigating this drug for quite some time. We steadfastly believe in the merits of this litigation. This vaccination is at best 50 percent effective. Either it is not effective or it causes shingles or a host of other side effects.” Bern added that “what is most troubling is that Merck had a better alternative on hand when this product was released.”

Sunday, March 26, 2017

Pivotal Lawsuit Shows Widely Used Antidepressant Increases Suicide Risk Over 800 Percent

A trial is currently underway in Illinois as a widow seeks to hold pharmaceutical manufacturer GlaxoSmithKline accountable for improper labeling and minimizing a potentially serious side effect of a well-known antidepressant.


Paroxetine is a widely prescribed antidepressant and anti-anxiety drug under the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Paroxetine is most commonly known as the brand name of Paxil, manufactured by GlaxoSmithKline (GSK). 



Since 2012, Wendy Dolin has been engaged in a legal battle against GSK following the suicide of her husband, Stewart Dolin. Wendy says that in the summer of 2010, Stewart was prescribed a generic version of Paxil for anxiety issues related to work. According to Wendy, Stewart Dolin complained of becoming increasingly anxious and restless and was unable to sleep while taking the drug. On July 15, 2010, less than one week after beginning this medication, Stewart committed suicide by walking in front of a train.


Wendy began searching for answers in the wake of her husband’s suicide and said she learned that he had been displaying signs of akathisia, a disorder characterized by an individual’s inability to relax or sit still. Psychiatrist Joseph Glenmullen said in 2006 that “Patients have described [akathisia] to me as listening to nails scratching on a black board 24/7, or your bones rattling like tuning forks. It is this inner agitation that is by far the most dangerous.” In 2012, Wendy filed a legal complaint against GSK seeking to hold the manufacturer liable for her husband’s death. The complaint noted that “a scientist working for another SSRI manufacturer, Pfizer, wrote in a 1998 medical journal article that the suicidal impulses resulting from akathisia may be explained as a feeling that ‘death is a welcome result’ when the ‘acutely discomforting symptoms of akathisia are experienced on top of already distressing disorders.’”



READ MORE:  Court Finds Speed Cameras "Unconstitutional" -- Forces City to Repay ALL Tickets



The critical issue in Wendy Dolin’s lawsuit is not simply paroxetine itself. It’s no secret that lawsuits against pharmaceutical companies are usually complicated under most circumstances, but this case is particularly notable as a tragic example of the gray area of liability when a patient is prescribed a generic drug, as well as the problems between the FDA and drugmakers that exist when it comes to publishing safety labels for patients and doctors.


It’s important to distinguish that Stewart Dolin was not prescribed the brand of Paxil, but a generic brand of paroxetine that was manufactured by another company, Mylan. Brent Wisner, Wendy Dolin’s attorney, described the issue as a “donut hole of liability” in which both the generic and the original manufacturer deny responsibility. “That’s where you have the generic maker on one hand saying, ‘We don’t know about these risks. We can’t be held responsible for them… plus, we can’t change the label,"” Wisner said according to an NBC investigative report. Winner added that “the brand name makers are saying, ‘Well, we didn’t make the pill."”



Generic drugs are often prescribed in place of specific brands, mainly to save costs, as generic drugs cost far less than brand names on average. In Illinois, where the Dolin family resided, “state pharmaceutical laws actually require such a substitution unless a doctor has advised against it. Some of the few courts that have sided with plaintiffs in generic-drug injury cases have also highlighted this conundrum for generic-drug plaintiffs,” according to a Law360 report on Wendy’s case.


Wendy and Wisner claim that the warning label that was given to the generic brand was “factually incorrect and misleading.” In their lawsuit, they allege that “the paroxetine label in existence at the time of Stewart Dolin’s death did not warn of the drug’s association with an increased risk of suicidal behavior in adults despite GSK’s knowledge of a statistically significant 6.7 times greater risk in adults of all ages. In fact, the label stated the opposite – that the suicidality risk did not extend beyond the age of 24.” Stewart Dolin was close to 57 when taking paroxetine.



READ MORE:  City Erects Prison Camp to Deal with Homeless - Cutting Off Food & Water



The lawsuit alleges that GSK whitewashed the suicide risks of Paxil in its data given to the FDA. The complaint explains that in 1989, GSK”s “Integrated Summary of Safety Information,” required to gain approval from the FDA, included a presentation identifying the number of suicide and suicide attempts during clinical trials. The suit alleges that GSK’s summary “skewed the statistical analysis of the data presented and obscured the true risk” by including suicide attempts “of placebo patients that had taken place in the placebo run-in (or wash-out) phase” before the clinical trials began. “Run-in” or “wash-out” refers to a time period of removing any other drugs in a trial participant’s system; any “adverse events” that take place during those periods are not appropriate or generally accepted for inclusion in calculations during clinical trials, the suit claims.


The Cook County Record reports that while those warning labels on Paxil and paroxetine were approved by the FDA, GSK said it was not allowed by the FDA to include an additional warning of a “statistically significant increase in the frequency of suicidal behavior in patients treated with paroxetine.” GSK claims that the FDA wanted to maintain homogeneous warnings among all antidepressants.


However, U.S. District Judge James Zagel noted that GSK “never asked for a formal meeting, nor did it seek additional labeling regarding Paxil-specific data” in a February 2016 ruling, and further wrote that “Moreover, GSK never sent a separate supplement and declined the FDA’s invitation for a meeting to discuss the inclusion of … the adult warnings.”



The trial against GSK is in progress and is expected to last a few weeks. Bob Fiddaman, a blogger and author who has written extensively about his own experiences with paroxetine, has been covering the developments of the trial. Fiddaman wrote that a “startling revelation” was unveiled on March 22nd:



Attorneys representing widow Wendy Dolin showed the ratio of Paxil-induced suicidality in adults is a staggering 8.9.  It is not 6.7, as previously claimed and reported by Glaxo. The 6.7 figure is astoundingly high in itself, but the 8.9 ratio is flabbergasting!



Plaintiff witness, Dr. David Ross, said this figure is ‘astounding.’ What you should remember here is that GSK’s 1989 drug application for Paxil said the suicidality odds ratio was 2.6.



Fiddaman wrote that Dr. Ross, who worked for the FDA for ten years, offered lengthy testimony. Fiddaman points out that Dr. Ross discussed the problematic relationship between the FDA and drug manufacturers. The FDA relies heavily on the accuracy of the data that is provided by drug companies, which is problematic when the companies present arguable data.




READ MORE:  NYPD Cop Tries to "Cop a Feel" on a Woman, Her Friend Tries to Film it, So they Assault and Kidnap Him



GSK’s argument has summarily been that they do not bear liability because the drug that was prescribed to Stewart Dolin was not manufactured by Mylan, not GSK. The company has stated that “we remain consistent in our stance that since GSK did not manufacture or market the generic paroxetine ingested by Mr. Dolin, it should not be held liable in this trial.”